Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Urticaria
ADR ID BADD_A04469
ADR Hierarchy
10      Immune system disorders
10.01      Allergic conditions
10.01.06      Urticarias
10.01.06.001      Urticaria
23      Skin and subcutaneous tissue disorders
23.04      Angioedema and urticaria
23.04.02      Urticarias
23.04.02.001      Urticaria
Description A disorder characterized by an itchy skin eruption characterized by wheals with pale interiors and well-defined red margins. [CTCAE] A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress. [MeSH]
MedDRA Code 10046735
MeSH ID D014581
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Acute allergic urticaria | Acute urticaria | Allergic urticaria | Erythema urticarial | Generalised urticarial | Generalised urticarial rash | Histamine-like rash | Hives | Nettle rash | Other specified urticaria | Pharmacological urticaria | Rash urticaria-like | Rash urticarial | Subcutaneous urticaria | Unspecified urticaria | Urticaria | Urticaria acute | Urticaria aggravated | Urticaria NOS | Urticaria subcutaneous | Urticaria, unspecified | Urticarial | Urticarial rash | Urticarial symptom | Urticated rash | Urtication | Welts | Wheals | Generalized urticaria | Urticaria generalised | Urticaria drug-induced | Urticaria localised | Urticaria localized | Generalized urticarial rash | Urticaria recurrent | Generalised urticaria | Atopic urticaria | Urticarias
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01259Leucovorin calcium--
BADD_D01260Leuprolide acetate--
BADD_D01261Leuprolide monoacetate--
BADD_D01262Levalbuterol--
BADD_D01263Levalbuterol hydrochloride--
BADD_D01264Levalbuterol tartrate--
BADD_D01267Levobunolol--
BADD_D01268Levobunolol hydrochloride--
BADD_D01269Levobupivacaine--
BADD_D01272Levocetirizine0.000194%
BADD_D01273Levocetirizine dihydrochloride--
BADD_D01275Levofloxacin0.004137%
BADD_D01280Levomilnacipran hydrochloride--
BADD_D01281Levonorgestrel--
BADD_D01282Levorphanol--
BADD_D01283Levorphanol tartrate--
BADD_D01285Levothyroxine0.000367%
BADD_D01286Levothyroxine sodium--
BADD_D01287Lidocaine0.000521%
BADD_D01288Lidocaine hydrochloride--
BADD_D01291Linaclotide--
BADD_D01292Linagliptin0.010385%
BADD_D01293Lincomycin hydrochloride--
BADD_D01294Lindane--
BADD_D01295Linezolid--
BADD_D01298Liraglutide--
BADD_D01299Lisdexamfetamine dimesylate--
BADD_D01300Lisinopril0.000328%
BADD_D01306Lixisenatide--
BADD_D01309Lomefloxacin--
The 24th Page    First    Pre   24 25 26 27 28    Next   Last    Total 45 Pages
ADReCS-Target
ADR Term Drug Name Target